Skip to main content
PMC home page
Gut logoLink to Gut
. 2000 Sep;47(3):444–454. doi: 10.1136/gut.47.3.444

Quality of life measurement in gastrointestinal and liver disorders

M BORGAONKAR 1, E IRVINE 1
PMCID: PMC1728037  PMID: 10940286

Abstract

Modern medicine has had a considerable impact on mortality rates for serious illness. Many chronic diseases which have previously been associated with an increased mortality now have survival rates approaching those of the background population. However, chronic diseases such as cancer, chronic pain syndromes, and chronic inflammatory conditions impose a considerable burden on families, the health care system, and society. Health related quality of life (HRQOL) is a concept that has developed from the need to estimate the impact of such chronic diseases. HRQOL measurement is a conceptual framework which attempts to predict daily function and well being based on subjective attitudes and experiences of physical, social, and emotional health. It has been evaluated predominantly from the patient's viewpoint as proxy respondents appear to underestimate the full effect of chronic illness on functional status. Measuring HRQOL in clinical research is most frequently undertaken using multi-item questionnaires to estimate daily function. Factors which affect HRQOL can be broadly classed as disease related and disease independent. The use of different assessment techniques permits comparisons between and within disorders. Generic and disease specific instruments used together enhance the ability to direct treatment for individuals and patient populations. Psychometrically sound questionnaires must be used. However, the type of instrument and research methods adopted depend on the question of interest. We have attempted to catalogue and critically assess the disease specific instruments used in the assessment of chronic gastrointestinal disease.



Full Text

The Full Text of this article is available as a PDF (196.1 KB).

Figure 1  .

Figure 1  

Open in a new tab

Number of quality of life related citations in the fields of gastroenterology and hepatology obtained from MEDLINE searches over different time intervals.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aaronson N. K., Ahmedzai S., Bergman B., Bullinger M., Cull A., Duez N. J., Filiberti A., Flechtner H., Fleishman S. B., de Haes J. C. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993 Mar 3;85(5):365–376. doi: 10.1093/jnci/85.5.365. [DOI] [PubMed] [Google Scholar]
  2. Adang E. M., Engel G. L., Rutten F. F., Geerdes B. P., Baeten C. G. Cost-effectiveness of dynamic graciloplasty in patients with fecal incontinence. Dis Colon Rectum. 1998 Jun;41(6):725–734. doi: 10.1007/BF02236259. [DOI] [PubMed] [Google Scholar]
  3. Alter M. J., Kruszon-Moran D., Nainan O. V., McQuillan G. M., Gao F., Moyer L. A., Kaslow R. A., Margolis H. S. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med. 1999 Aug 19;341(8):556–562. doi: 10.1056/NEJM199908193410802. [DOI] [PubMed] [Google Scholar]
  4. Angelini F., Nassuato G., Okolicsanji L., Toso S., Corbetti F., Zacchi C. Prevalenza delle lesioni diffuse e focali del parenchima epatico in uná popolazione residente, non selezionata. Studio prospettico ecografico. Radiol Med. 1990 May;79(5):470–473. [PubMed] [Google Scholar]
  5. Baeten C. G., Geerdes B. P., Adang E. M., Heineman E., Konsten J., Engel G. L., Kester A. D., Spaans F., Soeters P. B. Anal dynamic graciloplasty in the treatment of intractable fecal incontinence. N Engl J Med. 1995 Jun 15;332(24):1600–1605. doi: 10.1056/NEJM199506153322403. [DOI] [PubMed] [Google Scholar]
  6. Bamfi F., Olivieri A., Arpinelli F., De Carli G., Recchia G., Gandolfi L., Norberto L., Pacini F., Surrenti C., Irvine S. H. Measuring quality of life in dyspeptic patients: development and validation of a new specific health status questionnaire: final report from the Italian QPD project involving 4000 patients. Am J Gastroenterol. 1999 Mar;94(3):730–738. doi: 10.1111/j.1572-0241.1999.00944.x. [DOI] [PubMed] [Google Scholar]
  7. Barr H., Krasner N. Prospective quality-of-life analysis after palliative photoablation for the treatment of malignant dysphagia. Cancer. 1991 Oct 1;68(7):1660–1664. doi: 10.1002/1097-0142(19911001)68:7<1660::aid-cncr2820680733>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
  8. Bellentani S., Tiribelli C., Saccoccio G., Sodde M., Fratti N., De Martin C., Cristianini G. Prevalence of chronic liver disease in the general population of northern Italy: the Dionysos Study. Hepatology. 1994 Dec;20(6):1442–1449. doi: 10.1002/hep.1840200611. [DOI] [PubMed] [Google Scholar]
  9. Bergner M., Bobbitt R. A., Carter W. B., Gilson B. S. The Sickness Impact Profile: development and final revision of a health status measure. Med Care. 1981 Aug;19(8):787–805. doi: 10.1097/00005650-198108000-00001. [DOI] [PubMed] [Google Scholar]
  10. Bethge N., Sommer A., Vakil N. A prospective trial of self-expanding metal stents in the palliation of malignant esophageal strictures near the upper esophageal sphincter. Gastrointest Endosc. 1997 Mar;45(3):300–303. doi: 10.1016/s0016-5107(97)70275-x. [DOI] [PubMed] [Google Scholar]
  11. Blazeby J. M., Alderson D., Winstone K., Steyn R., Hammerlid E., Arraras J., Farndon J. R. Development of an EORTC questionnaire module to be used in quality of life assessment for patients with oesophageal cancer. The EORTC Quality of Life Study Group. Eur J Cancer. 1996 Oct;32A(11):1912–1917. doi: 10.1016/0959-8049(96)00199-2. [DOI] [PubMed] [Google Scholar]
  12. Blazeby J. M., Williams M. H., Brookes S. T., Alderson D., Farndon J. R. Quality of life measurement in patients with oesophageal cancer. Gut. 1995 Oct;37(4):505–508. doi: 10.1136/gut.37.4.505. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Bonkovsky H. L., Woolley J. M. Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy. The Consensus Interferon Study Group. Hepatology. 1999 Jan;29(1):264–270. doi: 10.1002/hep.510290124. [DOI] [PubMed] [Google Scholar]
  14. Branicki F. J., Law S. Y., Fok M., Poon R. T., Chu K. M., Wong J. Quality of life in patients with cancer of the esophagus and gastric cardia: a case for palliative resection. Arch Surg. 1998 Mar;133(3):316–322. doi: 10.1001/archsurg.133.3.316. [DOI] [PubMed] [Google Scholar]
  15. Buhl K., Lehnert T., Schlag P., Herfarth C. Reconstruction after gastrectomy and quality of life. World J Surg. 1995 Jul-Aug;19(4):558–564. doi: 10.1007/BF00294722. [DOI] [PubMed] [Google Scholar]
  16. Camilleri-Brennan J., Steele R. J. Quality of life after treatment for rectal cancer. Br J Surg. 1998 Aug;85(8):1036–1043. doi: 10.1046/j.1365-2168.1998.00808.x. [DOI] [PubMed] [Google Scholar]
  17. Chassany O., Marquis P., Scherrer B., Read N. W., Finger T., Bergmann J. F., Fraitag B., Geneve J., Caulin C. Validation of a specific quality of life questionnaire for functional digestive disorders. Gut. 1999 Apr;44(4):527–533. doi: 10.1136/gut.44.4.527. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Collins S. M. Is the irritable gut an inflamed gut? Scand J Gastroenterol Suppl. 1992;192:102–105. doi: 10.3109/00365529209095988. [DOI] [PubMed] [Google Scholar]
  19. Colombel J. F., Yazdanpanah Y., Laurent F., Houcke P., Delas N., Marquis P. Qualité de vie dans les maladies inflammatoires chroniques de l'intestin. Validation d'un questionnaire et premières données françaises. Gastroenterol Clin Biol. 1996;20(12):1071–1077. [PubMed] [Google Scholar]
  20. Davies J., Johnston D., Sue-Ling H., Young S., May J., Griffith J., Miller G., Martin I. Total or subtotal gastrectomy for gastric carcinoma? A study of quality of life. World J Surg. 1998 Oct;22(10):1048–1055. doi: 10.1007/s002689900515. [DOI] [PubMed] [Google Scholar]
  21. Dimenäs E., Glise H., Hallerbäck B., Hernqvist H., Svedlund J., Wiklund I. Well-being and gastrointestinal symptoms among patients referred to endoscopy owing to suspected duodenal ulcer. Scand J Gastroenterol. 1995 Nov;30(11):1046–1052. doi: 10.3109/00365529509101605. [DOI] [PubMed] [Google Scholar]
  22. Dominitz J. A., Provenzale D. Patient preferences and quality of life associated with colorectal cancer screening. Am J Gastroenterol. 1997 Dec;92(12):2171–2178. [PubMed] [Google Scholar]
  23. Drossman D. A., Leserman J., Li Z. M., Mitchell C. M., Zagami E. A., Patrick D. L. The rating form of IBD patient concerns: a new measure of health status. Psychosom Med. 1991 Nov-Dec;53(6):701–712. doi: 10.1097/00006842-199111000-00010. [DOI] [PubMed] [Google Scholar]
  24. Drossman D. A., Leserman J., Mitchell C. M., Li Z. M., Zagami E. A., Patrick D. L. Health status and health care use in persons with inflammatory bowel disease. A national sample. Dig Dis Sci. 1991 Dec;36(12):1746–1755. doi: 10.1007/BF01296620. [DOI] [PubMed] [Google Scholar]
  25. Drossman D. A., Whitehead W. E., Camilleri M. Irritable bowel syndrome: a technical review for practice guideline development. Gastroenterology. 1997 Jun;112(6):2120–2137. doi: 10.1053/gast.1997.v112.agast972120. [DOI] [PubMed] [Google Scholar]
  26. Drummond H. E., Ghosh S., Ferguson A., Brackenridge D., Tiplady B. Electronic quality of life questionnaires: a comparison of pen-based electronic questionnaires with conventional paper in a gastrointestinal study. Qual Life Res. 1995 Feb;4(1):21–26. doi: 10.1007/BF00434379. [DOI] [PubMed] [Google Scholar]
  27. Durand-Zaleski I., Earlam S., Fordy C., Davies M., Allen-Mersh T. G. Cost-effectiveness of systemic and regional chemotherapy for the treatment of patients with unresectable colorectal liver metastases. Cancer. 1998 Sep 1;83(5):882–888. [PubMed] [Google Scholar]
  28. Earlam S., Glover C., Fordy C., Burke D., Allen-Mersh T. G. Relation between tumor size, quality of life, and survival in patients with colorectal liver metastases. J Clin Oncol. 1996 Jan;14(1):171–175. doi: 10.1200/JCO.1996.14.1.171. [DOI] [PubMed] [Google Scholar]
  29. Eypasch E., Williams J. I., Wood-Dauphinee S., Ure B. M., Schmülling C., Neugebauer E., Troidl H. Gastrointestinal Quality of Life Index: development, validation and application of a new instrument. Br J Surg. 1995 Feb;82(2):216–222. doi: 10.1002/bjs.1800820229. [DOI] [PubMed] [Google Scholar]
  30. Farmer R. G., Easley K. A., Farmer J. M. Quality of life assessment by patients with inflammatory bowel disease. Cleve Clin J Med. 1992 Jan-Feb;59(1):35–42. doi: 10.3949/ccjm.59.1.35. [DOI] [PubMed] [Google Scholar]
  31. Farup C. E., Leidy N. K., Murray M., Williams G. R., Helbers L., Quigley E. M. Effect of domperidone on the health-related quality of life of patients with symptoms of diabetic gastroparesis. Diabetes Care. 1998 Oct;21(10):1699–1706. doi: 10.2337/diacare.21.10.1699. [DOI] [PubMed] [Google Scholar]
  32. Fass R., Fullerton S., Naliboff B., Hirsh T., Mayer E. A. Sexual dysfunction in patients with irritable bowel syndrome and non-ulcer dyspepsia. Digestion. 1998;59(1):79–85. doi: 10.1159/000007471. [DOI] [PubMed] [Google Scholar]
  33. Fattovich G., Giustina G., Degos F., Tremolada F., Diodati G., Almasio P., Nevens F., Solinas A., Mura D., Brouwer J. T. Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. Gastroenterology. 1997 Feb;112(2):463–472. doi: 10.1053/gast.1997.v112.pm9024300. [DOI] [PubMed] [Google Scholar]
  34. Feagan B. G., Rochon J., Fedorak R. N., Irvine E. J., Wild G., Sutherland L., Steinhart A. H., Greenberg G. R., Gillies R., Hopkins M. Methotrexate for the treatment of Crohn's disease. The North American Crohn's Study Group Investigators. N Engl J Med. 1995 Feb 2;332(5):292–297. doi: 10.1056/NEJM199502023320503. [DOI] [PubMed] [Google Scholar]
  35. Fitzpatrick R., Fletcher A., Gore S., Jones D., Spiegelhalter D., Cox D. Quality of life measures in health care. I: Applications and issues in assessment. BMJ. 1992 Oct 31;305(6861):1074–1077. doi: 10.1136/bmj.305.6861.1074. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Foster G. R., Goldin R. D., Thomas H. C. Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis. Hepatology. 1998 Jan;27(1):209–212. doi: 10.1002/hep.510270132. [DOI] [PubMed] [Google Scholar]
  37. Galmiche J. P., Barthelemy P., Hamelin B. Treating the symptoms of gastro-oesophageal reflux disease: a double-blind comparison of omeprazole and cisapride. Aliment Pharmacol Ther. 1997 Aug;11(4):765–773. doi: 10.1046/j.1365-2036.1997.00185.x. [DOI] [PubMed] [Google Scholar]
  38. Garrett J. W., Drossman D. A. Health status in inflammatory bowel disease. Biological and behavioral considerations. Gastroenterology. 1990 Jul;99(1):90–96. doi: 10.1016/0016-5085(90)91234-w. [DOI] [PubMed] [Google Scholar]
  39. Glia A., Lindberg G. Quality of life in patients with different types of functional constipation. Scand J Gastroenterol. 1997 Nov;32(11):1083–1089. doi: 10.3109/00365529709002985. [DOI] [PubMed] [Google Scholar]
  40. Glise H. Quality of life and cost of therapy in reflux disease. Scand J Gastroenterol Suppl. 1995;210:38–42. doi: 10.3109/00365529509090268. [DOI] [PubMed] [Google Scholar]
  41. Greenberg G. R., Feagan B. G., Martin F., Sutherland L. R., Thomson A. B., Williams C. N., Nilsson L. G., Persson T. Oral budesonide for active Crohn's disease. Canadian Inflammatory Bowel Disease Study Group. N Engl J Med. 1994 Sep 29;331(13):836–841. doi: 10.1056/NEJM199409293311303. [DOI] [PubMed] [Google Scholar]
  42. Grogono A. W., Woodgate D. J. Index for measuring health. Lancet. 1971 Nov;2(7732):1024–1026. doi: 10.1016/s0140-6736(71)90336-9. [DOI] [PubMed] [Google Scholar]
  43. Gross C. R., Malinchoc M., Kim W. R., Evans R. W., Wiesner R. H., Petz J. L., Crippin J. S., Klintmalm G. B., Levy M. F., Ricci P. Quality of life before and after liver transplantation for cholestatic liver disease. Hepatology. 1999 Feb;29(2):356–364. doi: 10.1002/hep.510290229. [DOI] [PubMed] [Google Scholar]
  44. Guillemin F., Bombardier C., Beaton D. Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol. 1993 Dec;46(12):1417–1432. doi: 10.1016/0895-4356(93)90142-n. [DOI] [PubMed] [Google Scholar]
  45. Guyatt G. H., Feeny D. H., Patrick D. L. Measuring health-related quality of life. Ann Intern Med. 1993 Apr 15;118(8):622–629. doi: 10.7326/0003-4819-118-8-199304150-00009. [DOI] [PubMed] [Google Scholar]
  46. Guyatt G., Mitchell A., Irvine E. J., Singer J., Williams N., Goodacre R., Tompkins C. A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology. 1989 Mar;96(3):804–810. [PubMed] [Google Scholar]
  47. Hahn B. A., Kirchdoerfer L. J., Fullerton S., Mayer E. Evaluation of a new quality of life questionnaire for patients with irritable bowel syndrome. Aliment Pharmacol Ther. 1997 Jun;11(3):547–552. doi: 10.1046/j.1365-2036.1997.00168.x. [DOI] [PubMed] [Google Scholar]
  48. Hahn B. A., Kirchdoerfer L. J., Fullerton S., Mayer E. Patient-perceived severity of irritable bowel syndrome in relation to symptoms, health resource utilization and quality of life. Aliment Pharmacol Ther. 1997 Jun;11(3):553–559. doi: 10.1046/j.1365-2036.1997.00160.x. [DOI] [PubMed] [Google Scholar]
  49. Hahn B. A., Yan S., Strassels S. Impact of irritable bowel syndrome on quality of life and resource use in the United States and United Kingdom. Digestion. 1999 Jan-Feb;60(1):77–81. doi: 10.1159/000007593. [DOI] [PubMed] [Google Scholar]
  50. Hallbök O., Hass U., Wänström A., Sjödahl R. Quality of life measurement after rectal excision for cancer. Comparison between straight and colonic J-pouch anastomosis. Scand J Gastroenterol. 1997 May;32(5):490–493. doi: 10.3109/00365529709025087. [DOI] [PubMed] [Google Scholar]
  51. Harris R. A., Kuppermann M., Richter J. E. Proton pump inhibitors or histamine-2 receptor antagonists for the prevention of recurrences of erosive reflux esophagitis: a cost-effectiveness analysis. Am J Gastroenterol. 1997 Dec;92(12):2179–2187. [PubMed] [Google Scholar]
  52. Havelund T., Lind T., Wiklund I., Glise H., Hernqvist H., Lauritsen K., Lundell L., Pedersen S. A., Carlsson R., Junghard O. Quality of life in patients with heartburn but without esophagitis: effects of treatment with omeprazole. Am J Gastroenterol. 1999 Jul;94(7):1782–1789. doi: 10.1111/j.1572-0241.1999.01206.x. [DOI] [PubMed] [Google Scholar]
  53. Hixson L. J., Kelley C. L., Jones W. N., Tuohy C. D. Current trends in the pharmacotherapy for gastroesophageal reflux disease. Arch Intern Med. 1992 Apr;152(4):717–723. [PubMed] [Google Scholar]
  54. Hjermstad M. J., Fossa S. D., Bjordal K., Kaasa S. Test/retest study of the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire. J Clin Oncol. 1995 May;13(5):1249–1254. doi: 10.1200/JCO.1995.13.5.1249. [DOI] [PubMed] [Google Scholar]
  55. Hjortswang H., Ström M., Almeida R. T., Almer S. Evaluation of the RFIPC, a disease-specific health-related quality of life questionnaire, in Swedish patients with ulcerative colitis. Scand J Gastroenterol. 1997 Dec;32(12):1235–1240. doi: 10.3109/00365529709028153. [DOI] [PubMed] [Google Scholar]
  56. Hunt C. M., Dominitz J. A., Bute B. P., Waters B., Blasi U., Williams D. M. Effect of interferon-alpha treatment of chronic hepatitis C on health-related quality of life. Dig Dis Sci. 1997 Dec;42(12):2482–2486. doi: 10.1023/a:1018852309885. [DOI] [PubMed] [Google Scholar]
  57. Irvine E. J., Feagan B. G., Wong C. J. Does self-administration of a quality of life index for inflammatory bowel disease change the results? J Clin Epidemiol. 1996 Oct;49(10):1177–1185. doi: 10.1016/0895-4356(96)00136-9. [DOI] [PubMed] [Google Scholar]
  58. Irvine E. J., Feagan B., Rochon J., Archambault A., Fedorak R. N., Groll A., Kinnear D., Saibil F., McDonald J. W. Quality of life: a valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease. Canadian Crohn's Relapse Prevention Trial Study Group. Gastroenterology. 1994 Feb;106(2):287–296. doi: 10.1016/0016-5085(94)90585-1. [DOI] [PubMed] [Google Scholar]
  59. Irvine E. J. Quality of life in inflammatory bowel disease and other chronic diseases. Scand J Gastroenterol Suppl. 1996;221:26–28. doi: 10.3109/00365529609095550. [DOI] [PubMed] [Google Scholar]
  60. Irvine E. J. Quality of life issues in patients with inflammatory bowel disease. Am J Gastroenterol. 1997 Dec;92(12 Suppl):18S–24S. [PubMed] [Google Scholar]
  61. Irvine E. J., Zhou Q., Thompson A. K. The Short Inflammatory Bowel Disease Questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. CCRPT Investigators. Canadian Crohn's Relapse Prevention Trial. Am J Gastroenterol. 1996 Aug;91(8):1571–1578. [PubMed] [Google Scholar]
  62. Ishihara K. Long-term quality of life in patients after total gastrectomy. Cancer Nurs. 1999 Jun;22(3):220–227. doi: 10.1097/00002820-199906000-00005. [DOI] [PubMed] [Google Scholar]
  63. Jentschura D., Winkler M., Strohmeier N., Rumstadt B., Hagmüller E. Quality-of-life after curative surgery for gastric cancer: a comparison between total gastrectomy and subtotal gastric resection. Hepatogastroenterology. 1997 Jul-Aug;44(16):1137–1142. [PubMed] [Google Scholar]
  64. Jeppesen P. B., Langholz E., Mortensen P. B. Quality of life in patients receiving home parenteral nutrition. Gut. 1999 Jun;44(6):844–852. doi: 10.1136/gut.44.6.844. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Johanson J. F., Sonnenberg A. The prevalence of hemorrhoids and chronic constipation. An epidemiologic study. Gastroenterology. 1990 Feb;98(2):380–386. doi: 10.1016/0016-5085(90)90828-o. [DOI] [PubMed] [Google Scholar]
  66. Kim W. H., Cho Y. S., Yoo H. M., Park I. S., Park E. C., Lim J. G. Quality of life in Korean patients with inflammatory bowel diseases: ulcerative colitis, Crohn's disease and intestinal Behçet's disease. Int J Colorectal Dis. 1999 Feb;14(1):52–57. doi: 10.1007/s003840050183. [DOI] [PubMed] [Google Scholar]
  67. King M. T., Dobson A. J., Harnett P. R. A comparison of two quality-of-life questionnaires for cancer clinical trials: the functional living index--cancer (FLIC) and the quality of life questionnaire core module (QLQ-C30). J Clin Epidemiol. 1996 Jan;49(1):21–29. doi: 10.1016/0895-4356(96)89258-4. [DOI] [PubMed] [Google Scholar]
  68. Ladefoged K., Jarnum S. Long-term parenteral nutrition. Br Med J. 1978 Jul 22;2(6132):262–266. doi: 10.1136/bmj.2.6132.262. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Langholz E., Munkholm P., Davidsen M., Binder V. Course of ulcerative colitis: analysis of changes in disease activity over years. Gastroenterology. 1994 Jul;107(1):3–11. doi: 10.1016/0016-5085(94)90054-x. [DOI] [PubMed] [Google Scholar]
  70. Levy M. F., Jennings L., Abouljoud M. S., Mulligan D. C., Goldstein R. M., Husberg B. S., Gonwa T. A., Klintmalm G. B. Quality of life improvements at one, two, and five years after liver transplantation. Transplantation. 1995 Feb 27;59(4):515–518. [PubMed] [Google Scholar]
  71. Locke G. R., Talley N. J., Weaver A. L., Zinsmeister A. R. A new questionnaire for gastroesophageal reflux disease. Mayo Clin Proc. 1994 Jun;69(6):539–547. doi: 10.1016/s0025-6196(12)62245-9. [DOI] [PubMed] [Google Scholar]
  72. Love J. R., Irvine E. J., Fedorak R. N. Quality of life in inflammatory bowel disease. J Clin Gastroenterol. 1992 Jan;14(1):15–19. doi: 10.1097/00004836-199201000-00005. [DOI] [PubMed] [Google Scholar]
  73. López-Vivancos J., Casellas F., Badia X., Vilaseca J., Malagelada J. R. Validation of the spanish version of the inflammatory bowel disease questionnaire on ulcerative colitis and Crohn's disease. Digestion. 1999;60(3):274–280. doi: 10.1159/000007670. [DOI] [PubMed] [Google Scholar]
  74. Martin A., Dinca M., Leone L., Fries W., Angriman I., Tropea A., Naccarato R. Quality of life after proctocolectomy and ileo-anal anastomosis for severe ulcerative colitis. Am J Gastroenterol. 1998 Feb;93(2):166–169. doi: 10.1111/j.1572-0241.1998.00166.x. [DOI] [PubMed] [Google Scholar]
  75. Martin A., Leone L., Fries W., Naccarato R. Quality of life in inflammatory bowel disease. Ital J Gastroenterol. 1995 Oct-Nov;27(8):450–454. [PubMed] [Google Scholar]
  76. Martin C., Marquis P., Bonfils S. A 'quality of life questionnaire' adapted to duodenal ulcer therapeutic trials. Scand J Gastroenterol Suppl. 1994;206:40–43. doi: 10.3109/00365529409091420. [DOI] [PubMed] [Google Scholar]
  77. Maunder R. G., de Rooy E. C., Toner B. B., Greenberg G. R., Steinhart A. H., McLeod R. S., Cohen Z. Health-related concerns of people who receive psychological support for inflammatory bowel disease. Can J Gastroenterol. 1997 Nov-Dec;11(8):681–685. doi: 10.1155/1997/183841. [DOI] [PubMed] [Google Scholar]
  78. McDougall N. I., Johnston B. T., Kee F., Collins J. S., McFarland R. J., Love A. H. Natural history of reflux oesophagitis: a 10 year follow up of its effect on patient symptomatology and quality of life. Gut. 1996 Apr;38(4):481–486. doi: 10.1136/gut.38.4.481. [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. Meshkinpour H., Haghighat P., Meshkinpour A. Quality of life among patients treated for achalasia. Dig Dis Sci. 1996 Feb;41(2):352–356. doi: 10.1007/BF02093828. [DOI] [PubMed] [Google Scholar]
  80. Mitchell A., Guyatt G., Singer J., Irvine E. J., Goodacre R., Tompkins C., Williams N., Wagner F. Quality of life in patients with inflammatory bowel disease. J Clin Gastroenterol. 1988 Jun;10(3):306–310. doi: 10.1097/00004836-198806000-00014. [DOI] [PubMed] [Google Scholar]
  81. Moore S. W., Albertyn R., Cywes S. Clinical outcome and long-term quality of life after surgical correction of Hirschsprung's disease. J Pediatr Surg. 1996 Nov;31(11):1496–1502. doi: 10.1016/s0022-3468(96)90164-5. [DOI] [PubMed] [Google Scholar]
  82. Moser G., Tillinger W., Sachs G., Genser D., Maier-Dobersberger T., Spiess K., Wyatt J., Vogelsang H., Lochs H., Gangl A. Disease-related worries and concerns: a study on out-patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol. 1995 Sep;7(9):853–858. [PubMed] [Google Scholar]
  83. Moyer C. A., Fendrick A. M. Measuring health-related quality of life in patients with upper gastrointestinal disease. Dig Dis. 1998 Sep-Oct;16(5):315–324. doi: 10.1159/000016881. [DOI] [PubMed] [Google Scholar]
  84. Navasa M., Forns X., Sánchez V., Andreu H., Marcos V., Borràs J. M., Rimola A., Grande L., García-Valdecasas J. C., Granados A. Quality of life, major medical complications and hospital service utilization in patients with primary biliary cirrhosis after liver transplantation. J Hepatol. 1996 Aug;25(2):129–134. doi: 10.1016/s0168-8278(96)80064-x. [DOI] [PubMed] [Google Scholar]
  85. Nebel O. T., Fornes M. F., Castell D. O. Symptomatic gastroesophageal reflux: incidence and precipitating factors. Am J Dig Dis. 1976 Nov;21(11):953–956. doi: 10.1007/BF01071906. [DOI] [PubMed] [Google Scholar]
  86. Ng S. C., Clements P. J., Berquist W. E., Furst D. E., Paulus H. E. Home central venous hyperalimentation in fifteen patients with severe scleroderma bowel disease. Arthritis Rheum. 1989 Feb;32(2):212–216. doi: 10.1002/anr.1780320216. [DOI] [PubMed] [Google Scholar]
  87. Nyam D. C., Pemberton J. H., Ilstrup D. M., Rath D. M. Long-term results of surgery for chronic constipation. Dis Colon Rectum. 1997 Mar;40(3):273–279. doi: 10.1007/BF02050415. [DOI] [PubMed] [Google Scholar]
  88. Patrick D. L., Drossman D. A., Frederick I. O., DiCesare J., Puder K. L. Quality of life in persons with irritable bowel syndrome: development and validation of a new measure. Dig Dis Sci. 1998 Feb;43(2):400–411. doi: 10.1023/a:1018831127942. [DOI] [PubMed] [Google Scholar]
  89. Pescatori M., Pavesio R., Anastasio G., Daini S. Transanal electrostimulation for fecal incontinence: clinical, psychologic, and manometric prospective study. Dis Colon Rectum. 1991 Jul;34(7):540–545. doi: 10.1007/BF02049891. [DOI] [PubMed] [Google Scholar]
  90. Provenzale D., Shearin M., Phillips-Bute B. G., Drossman D. A., Li Z., Tillinger W., Schmitt C. M., Bollinger R. R., Koruda M. J. Health-related quality of life after ileoanal pull-through evaluation and assessment of new health status measures. Gastroenterology. 1997 Jul;113(1):7–14. doi: 10.1016/s0016-5085(97)70074-x. [DOI] [PubMed] [Google Scholar]
  91. Rampal P., Martin C., Marquis P., Ware J. E., Bonfils S. A quality of life study in five hundred and eighty-one duodenal ulcer patients. Maintenance versus intermittent treatment with nizatidine. Scand J Gastroenterol Suppl. 1994;206:44–51. doi: 10.3109/00365529409091421. [DOI] [PubMed] [Google Scholar]
  92. Revicki D. A., Wood M., Wiklund I., Crawley J. Reliability and validity of the Gastrointestinal Symptom Rating Scale in patients with gastroesophageal reflux disease. Qual Life Res. 1998 Jan;7(1):75–83. doi: 10.1023/a:1008841022998. [DOI] [PubMed] [Google Scholar]
  93. Richards D. M., Irving M. H. Cost-utility analysis of home parenteral nutrition. Br J Surg. 1996 Sep;83(9):1226–1229. doi: 10.1046/j.1365-2168.1996.02308.x. [DOI] [PubMed] [Google Scholar]
  94. Rintala R., Lahdenne P., Lindahl H., Siimes M., Heikinheimo M. Anorectal function in adults operated for a benign sacrococcygeal teratoma. J Pediatr Surg. 1993 Sep;28(9):1165–1167. doi: 10.1016/0022-3468(93)90156-f. [DOI] [PubMed] [Google Scholar]
  95. Rintala R., Mildh L., Lindahl H. Fecal continence and quality of life in adult patients with an operated low anorectal malformation. J Pediatr Surg. 1992 Jul;27(7):902–905. doi: 10.1016/0022-3468(92)90394-m. [DOI] [PubMed] [Google Scholar]
  96. Rush D. R., Stelmach W. J., Young T. L., Kirchdoerfer L. J., Scott-Lennox J., Holverson H. E., Sabesin S. M., Nicholas T. A. Clinical effectiveness and quality of life with ranitidine vs placebo in gastroesophageal reflux disease patients: a clinical experience network (CEN) study. J Fam Pract. 1995 Aug;41(2):126–136. [PubMed] [Google Scholar]
  97. Russel M. G., Pastoor C. J., Brandon S., Rijken J., Engels L. G., van der Heijde D. M., Stockbrügger R. W. Validation of the Dutch translation of the Inflammatory Bowel Disease Questionnaire (IBDQ): a health-related quality of life questionnaire in inflammatory bowel disease. Digestion. 1997;58(3):282–288. doi: 10.1159/000201455. [DOI] [PubMed] [Google Scholar]
  98. Sailer M., Bussen D., Debus E. S., Fuchs K. H., Thiede A. Quality of life in patients with benign anorectal disorders. Br J Surg. 1998 Dec;85(12):1716–1719. doi: 10.1046/j.1365-2168.1998.00958.x. [DOI] [PubMed] [Google Scholar]
  99. Sandler R. S. Epidemiology of irritable bowel syndrome in the United States. Gastroenterology. 1990 Aug;99(2):409–415. doi: 10.1016/0016-5085(90)91023-y. [DOI] [PubMed] [Google Scholar]
  100. Somerville K. W., Langman M. J., Kane S. P., MacGilchrist A. J., Watkinson G., Salmon P. Effect of treatment on symptoms and quality of life in patients with ulcerative colitis: comparative trial of hydrocortisone acetate foam and prednisolone 21-phosphate enemas. Br Med J (Clin Res Ed) 1985 Sep 28;291(6499):866–866. doi: 10.1136/bmj.291.6499.866. [DOI] [PMC free article] [PubMed] [Google Scholar]
  101. Sonnenberg A. Disability and need for rehabilitation among patients with inflammatory bowel disease. Digestion. 1992;51(3):168–178. doi: 10.1159/000200893. [DOI] [PubMed] [Google Scholar]
  102. Soykan I., Sarosiek I., McCallum R. W. The effect of chronic oral domperidone therapy on gastrointestinal symptoms, gastric emptying, and quality of life in patients with gastroparesis. Am J Gastroenterol. 1997 Jun;92(6):976–980. [PubMed] [Google Scholar]
  103. Svedlund J., Sjödin I., Dotevall G. GSRS--a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci. 1988 Feb;33(2):129–134. doi: 10.1007/BF01535722. [DOI] [PubMed] [Google Scholar]
  104. Svedlund J., Sullivan M., Liedman B., Lundell L. Long term consequences of gastrectomy for patient's quality of life: the impact of reconstructive techniques. Am J Gastroenterol. 1999 Feb;94(2):438–445. doi: 10.1111/j.1572-0241.1999.874_c.x. [DOI] [PubMed] [Google Scholar]
  105. Talley N. J., Phillips S. F., Melton J., 3rd, Wiltgen C., Zinsmeister A. R. A patient questionnaire to identify bowel disease. Ann Intern Med. 1989 Oct 15;111(8):671–674. doi: 10.7326/0003-4819-111-8-671. [DOI] [PubMed] [Google Scholar]
  106. Talley N. J. Quality of life in functional dyspepsia. Scand J Gastroenterol Suppl. 1996;221:21–22. doi: 10.3109/00365529609095547. [DOI] [PubMed] [Google Scholar]
  107. Talley N. J. Scope of the problem of functional digestive disorders. Eur J Surg Suppl. 1998;(582):35–41. doi: 10.1080/11024159850191427. [DOI] [PubMed] [Google Scholar]
  108. Talley N. J., Zinsmeister A. R., Schleck C. D., Melton L. J., 3rd Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology. 1992 Apr;102(4 Pt 1):1259–1268. [PubMed] [Google Scholar]
  109. Thybusch-Bernhardt A., Schmidt C., Küchler T., Schmid A., Henne-Bruns D., Kremer B. Quality of life following radical surgical treatment of gastric carcinoma. World J Surg. 1999 May;23(5):503–508. doi: 10.1007/pl00012339. [DOI] [PubMed] [Google Scholar]
  110. Troidl H., Kusche J., Vestweber K. H., Eypasch E., Koeppen L., Bouillon B. Quality of life: an important endpoint both in surgical practice and research. J Chronic Dis. 1987;40(6):523–528. doi: 10.1016/0021-9681(87)90009-9. [DOI] [PubMed] [Google Scholar]
  111. Vakil N., Huilgol V., Khan I. Effect of push enteroscopy on transfusion requirements and quality of life in patients with unexplained gastrointestinal bleeding. Am J Gastroenterol. 1997 Mar;92(3):425–428. [PubMed] [Google Scholar]
  112. Velanovich V. Comparison of generic (SF-36) vs. disease-specific (GERD-HRQL) quality-of-life scales for gastroesophageal reflux disease. J Gastrointest Surg. 1998 Mar-Apr;2(2):141–145. doi: 10.1016/s1091-255x(98)80004-8. [DOI] [PubMed] [Google Scholar]
  113. Velanovich V., Karmy-Jones R. Measuring gastroesophageal reflux disease: relationship between the Health-Related Quality of Life score and physiologic parameters. Am Surg. 1998 Jul;64(7):649–653. [PubMed] [Google Scholar]
  114. Velanovich V., Vallance S. R., Gusz J. R., Tapia F. V., Harkabus M. A. Quality of life scale for gastroesophageal reflux disease. J Am Coll Surg. 1996 Sep;183(3):217–224. [PubMed] [Google Scholar]
  115. Veldhuyzen van Zanten S. J., Tytgat K. M., Pollak P. T., Goldie J., Goodacre R. L., Riddell R. H., Hunt R. H. Can severity of symptoms be used as an outcome measure in trials of non-ulcer dyspepsia and Helicobacter pylori associated gastritis? J Clin Epidemiol. 1993 Mar;46(3):273–279. doi: 10.1016/0895-4356(93)90075-c. [DOI] [PubMed] [Google Scholar]
  116. Veldhuyzen van Zanten S. Problems in measurement of quality of life in dyspepsia trials. Eur J Surg Suppl. 1998;(583):77–80. doi: 10.1080/11024159850191292. [DOI] [PubMed] [Google Scholar]
  117. Ware J. E., Jr, Sherbourne C. D. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992 Jun;30(6):473–483. [PubMed] [Google Scholar]
  118. Webb A., Cunningham D., Scarffe J. H., Harper P., Norman A., Joffe J. K., Hughes M., Mansi J., Findlay M., Hill A. Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer. J Clin Oncol. 1997 Jan;15(1):261–267. doi: 10.1200/JCO.1997.15.1.261. [DOI] [PubMed] [Google Scholar]
  119. Whitehead W. E., Burnett C. K., Cook E. W., 3rd, Taub E. Impact of irritable bowel syndrome on quality of life. Dig Dis Sci. 1996 Nov;41(11):2248–2253. doi: 10.1007/BF02071408. [DOI] [PubMed] [Google Scholar]
  120. Wiklund I. K., Junghard O., Grace E., Talley N. J., Kamm M., Veldhuyzen van Zanten S., Paré P., Chiba N., Leddin D. S., Bigard M. A. Quality of Life in Reflux and Dyspepsia patients. Psychometric documentation of a new disease-specific questionnaire (QOLRAD). Eur J Surg Suppl. 1998;(583):41–49. [PubMed] [Google Scholar]
  121. Willcox R. R. Epidemiology of anorectal disease: a review. J R Soc Med. 1980 Jul;73(7):508–509. doi: 10.1177/014107688007300709. [DOI] [PMC free article] [PubMed] [Google Scholar]
  122. Wu C. W., Hsieh M. C., Lo S. S., Lui W. Y., P'eng F. K. Quality of life of patients with gastric adenocarcinoma after curative gastrectomy. World J Surg. 1997 Sep;21(7):777–782. doi: 10.1007/s002689900305. [DOI] [PubMed] [Google Scholar]
  123. Younossi Z. M., Guyatt G., Kiwi M., Boparai N., King D. Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease. Gut. 1999 Aug;45(2):295–300. doi: 10.1136/gut.45.2.295. [DOI] [PMC free article] [PubMed] [Google Scholar]
  124. Younossi Z. M., Guyatt G. Quality-of-life assessments and chronic liver disease. Am J Gastroenterol. 1998 Jul;93(7):1037–1041. doi: 10.1111/j.1572-0241.1998.00325.x. [DOI] [PubMed] [Google Scholar]
  125. Zaniboni A., Labianca R., Marsoni S., Torri V., Mosconi P., Grilli R., Apolone G., Cifani S., Tinazzi A. GIVIO-SITAC 01: A randomized trial of adjuvant 5-fluorouracil and folinic acid administered to patients with colon carcinoma--long term results and evaluation of the indicators of health-related quality of life. Gruppo Italiano Valutazione Interventi in Oncologia. Studio Italiano Terapia Adiuvante Colon. Cancer. 1998 Jun 1;82(11):2135–2144. doi: 10.1002/(sici)1097-0142(19980601)82:11<2135::aid-cncr7>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  126. Zbrozek A., Hoop R., Robinson M., McPherson M. Test of an instrument to measure function-related quality of life in patients with ulcerative colitis. Pharmacoeconomics. 1993 Jul;4(1):31–39. doi: 10.2165/00019053-199304010-00005. [DOI] [PubMed] [Google Scholar]
  127. Zieren H. U., Jacobi C. A., Zieren J., Müller J. M. Quality of life following resection of oesophageal carcinoma. Br J Surg. 1996 Dec;83(12):1772–1775. doi: 10.1002/bjs.1800831235. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES